Rapid Micro Biosystems (RMB) will be exhibiting at the 2019 Parenteral Drug Association (PDA) Annual Meeting, March 11 – 13, in San Diego, CA. RMB is excited to participate in this year’s meeting as part of the solution to Solving Manufacturing and Supply Challenges for Current and Future Medicinal Products.
Come visit our booth (#322) to discuss how Rapid Micro Biosystems Growth Direct™ can add tremendous value to your organization. Growth Direct is the first and only growth-based system to automate a rapid compendial QC Micro test for the Pharmaceutical Industry. Also, by detecting potential contamination 50% faster than traditional compendial methods, the Growth Direct ensures a higher standard in the following critical areas:
- Data Integrity and Compliance
- Increased Operational Efficiencies driven by Rapid Methods and Automation
- Higher Quality Products for Improved Patient Outcomes
If you would like to schedule a meeting to learn more about how Growth Direct can support your strategic initiatives and help bring your QC lab and manufacturing facility into the future, please click here.
If you are unable to join us at this event but would like to learn more about Growth Direct, please download the RMB brochure here.